Aspect Partners’s West Pharmaceutical WST Stock Holding History

Aspect Partners’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$5.56K	Sell	15 -11	-42%	-$3.88K	﹤0.01%	366
2026 Q2	$9.33K	Buy	26 +24	+1,200%	+$7.34K	﹤0.01%	290
2026 Q1	$501	Hold	2	–	–	﹤0.01%	657
2025 Q4	$550	Buy	+2	New	+$547	﹤0.01%	672
2024 Q2	–	Sell	-1	Closed	-$396	–	582
2024 Q1	$396	Hold	1	–	–	﹤0.01%	524
2023 Q4	$352	Buy	+1	New	+$354	﹤0.01%	517

Other funds holding WST

Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return

Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return

Vest Financial Mclean, Virginia $9.5B AUM 22.78% 1-Year Est. Return

AMI Asset Management Los Angeles, California $1.74B AUM 24.77% 1-Year Est. Return

Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

North Growth Management Vancouver, British Columbia, Canada $743M AUM 74.29% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Aspect Partners's WST Position: Q3 2026 in Review

Aspect Partners reduced its West Pharmaceutical (WST) stake by 42% in Q3 2026, selling an estimated $3.88K and leaving 15 shares worth $5.56K. The position accounts for ﹤0.01% of the portfolio, ranked #366.

Aspect Partners first reported a position in WST in Q4 2023 and has held it in 6 quarters since. The position peaked at $9.33K in Q2 2026. 189 funds tracked by Wall St. Rank hold WST as of Q3 2026.

Aspect Partners held 15 shares of West Pharmaceutical worth $5.56K as of Q3 2026.
Aspect Partners sold 11 West Pharmaceutical shares in Q3 2026, an estimated $3.88K.
West Pharmaceutical made up ﹤0.01% of Aspect Partners's portfolio in Q3 2026, its #366 holding.
Aspect Partners first reported a position in West Pharmaceutical in Q4 2023 and has held it in 6 quarters since.
Aspect Partners's West Pharmaceutical position peaked at $9.33K in Q2 2026.
189 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Aspect Partners's 13F filing for Q3 2026, filed 20 Oct 2026.